![]() |
Home | Products | Science | Order Now | Contact | Testimonials | News | In The Media | Complementary therapies |
|
Pure EPA Omega-3 Fish OilAs Seen On TV & In The National Press Welcome to our website, where you'll find information on our pharmaceutical-grade omega-3 fish oil supplement Vegepa. Vegepa was the first pure EPA fish oil health supplement to be formulated for specific conditions, and it has built a solid reputation with both practitioners and patients for a number of ailments, including: Pure EPA Fish Oil for Brain and BodyVegepa has been recommended in peer-reviewed scientific journals and used in clinical research. We pride ourselves on formulating scientifically-based premium brands, made entirely from natural ingredients. Our EPA fish oil supplements contain no chemical or artificial nasties, and we take no short-cuts when it comes to product formulation. Quality and efficacy are first and foremost our principal considerations in the development of our premium supplements.
Our supplements are not only taken religiously by those with specific conditions, however. Recognising the benefits of enjoying a healthy lifestyle, many people are now turning to supplementation in their bid to achieve vitality and well-being. For active individuals seeking more information about how EPA omega 3 fish oil can benefit your health and support your exercise regime, visit our sports nutrition website, Igennus Active Nutrition. For vegetarians and vegans we have developed Echiomega, a vegetarian omega 3 formulation which delivers superior health benefits over the commonly available vegetarian omega oil preparations. Visit our new Healthcare Nutrition website at www.igennus-hn.com to browse the new content and set up your personal account with Igennus to receive health news, offers and our quarterly newsletter OmegaMatters. To enable you to get familiar with the new site there will be a grace period, during which both sites will be active. Promotional codes and offers are available only via our new online shop. |
|
|